ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Interventional Pain Medicine

Top Interventional Pain Medicine Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LESLY POMPY MD

Interventional Pain Medicine

9,309

$503K

328
52 are 65+

60%
patients receiving schedule two controlled substances

Avg: 48%

72%
patients receiving schedule three controlled substances

Avg: 41%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 18%

$54
Average prescription price

Avg: $70

THOMAS BASCH MD

Interventional Pain Medicine

6,618

$501K

553
218 are 65+

68%
patients receiving schedule two controlled substances

Avg: 48%

35%
patients receiving schedule three controlled substances

Avg: 41%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 18%

$76
Average prescription price

Avg: $70

DAVID KRENCIK DO

Interventional Pain Medicine

5,909

$434K

426
181 are 65+

51%
patients receiving schedule two controlled substances

Avg: 48%

43%
patients receiving schedule three controlled substances

Avg: 41%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 18%

$73
Average prescription price

Avg: $70

KEVIN FITZGERALD MD

Interventional Pain Medicine

5,680

$303K

681
336 are 65+

57%
patients receiving schedule two controlled substances

Avg: 48%

33%
patients receiving schedule three controlled substances

Avg: 41%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 18%

$53
Average prescription price

Avg: $70

DANIEL MANKOFF MD

Interventional Pain Medicine

5,401

$306K

626
295 are 65+

66%
patients receiving schedule two controlled substances

Avg: 48%

40%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 18%

$57
Average prescription price

Avg: $70

KEITH JAVERY DO

Interventional Pain Medicine

5,170

$397K

502
157 are 65+

52%
patients receiving schedule two controlled substances

Avg: 48%

53%
patients receiving schedule three controlled substances

Avg: 41%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 18%

$77
Average prescription price

Avg: $70

SEAN GROWNEY DO

Interventional Pain Medicine

4,961

$236K

517
236 are 65+

53%
patients receiving schedule two controlled substances

Avg: 48%

52%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 18%

$48
Average prescription price

Avg: $70

MATTHEW KUIPER DO

Interventional Pain Medicine

4,839

$319K

582
266 are 65+

50%
patients receiving schedule two controlled substances

Avg: 48%

29%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 18%

$66
Average prescription price

Avg: $70

KULDIP DEOGUN M.D.

Interventional Pain Medicine

4,691

$508K

375
130 are 65+

76%
patients receiving schedule two controlled substances

Avg: 48%

41%
patients receiving schedule three controlled substances

Avg: 41%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 18%

$108
Average prescription price

Avg: $70

WILLIAM KOLE M.D.

Interventional Pain Medicine

4,573

$508K

367
117 are 65+

75%
patients receiving schedule two controlled substances

Avg: 48%

38%
patients receiving schedule three controlled substances

Avg: 41%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 18%

$111
Average prescription price

Avg: $70

MARK GOSTINE MD

Interventional Pain Medicine

4,036

$196K

442
229 are 65+

45%
patients receiving schedule two controlled substances

Avg: 48%

44%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 18%

$49
Average prescription price

Avg: $70

BARTON WILD MD

Interventional Pain Medicine

3,677

$223K

521
223 are 65+

55%
patients receiving schedule two controlled substances

Avg: 48%

31%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 18%

$61
Average prescription price

Avg: $70

SCOTT GREENWALD MD

Interventional Pain Medicine

3,340

$190K

452
203 are 65+

48%
patients receiving schedule two controlled substances

Avg: 48%

34%
patients receiving schedule three controlled substances

Avg: 41%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 18%

$57
Average prescription price

Avg: $70

LISA PULLUM DO

Interventional Pain Medicine

3,077

$162K

313
169 are 65+

35%
patients receiving schedule two controlled substances

Avg: 48%

47%
patients receiving schedule three controlled substances

Avg: 41%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 18%

$53
Average prescription price

Avg: $70

RAZMIG HALADJIAN M.D.

Interventional Pain Medicine

3,061

$239K

376
154 are 65+

57%
patients receiving schedule two controlled substances

Avg: 48%

50%
patients receiving schedule three controlled substances

Avg: 41%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 18%

$78
Average prescription price

Avg: $70

BENNETT WILLARD DO

Interventional Pain Medicine

3,017

$171K

467
259 are 65+

59%
patients receiving schedule two controlled substances

Avg: 48%

38%
patients receiving schedule three controlled substances

Avg: 41%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 18%

$57
Average prescription price

Avg: $70

STEPHEN WINSTON MD

Interventional Pain Medicine

2,740

$164K

436
229 are 65+

47%
patients receiving schedule two controlled substances

Avg: 48%

29%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 18%

$60
Average prescription price

Avg: $70

TAWFIQ NAKHLEH D.O.

Interventional Pain Medicine

2,688

$320K

324
93 are 65+

74%
patients receiving schedule two controlled substances

Avg: 48%

33%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 18%

$119
Average prescription price

Avg: $70

MARK CLARK M.D.

Interventional Pain Medicine

2,482

$117K

376
81 are 65+

46%
patients receiving schedule two controlled substances

Avg: 48%

48%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 18%

$47
Average prescription price

Avg: $70

FRED DAVIS MD

Interventional Pain Medicine

2,293

$130K

377
222 are 65+

49%
patients receiving schedule two controlled substances

Avg: 48%

39%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 18%

$57
Average prescription price

Avg: $70

WALID OSTA M.D.

Interventional Pain Medicine

2,247

$162K

207
46 are 65+

66%
patients receiving schedule two controlled substances

Avg: 48%

38%
patients receiving schedule three controlled substances

Avg: 41%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 18%

$72
Average prescription price

Avg: $70

CRAIG PEPPLER D.O.

Interventional Pain Medicine

1,939

$292K

115
41 are 65+

56%
patients receiving schedule two controlled substances

Avg: 48%

59%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 18%

$151
Average prescription price

Avg: $70

TIMOTHY WRIGHT MD

Interventional Pain Medicine

1,803

$135K

256
146 are 65+

57%
patients receiving schedule two controlled substances

Avg: 48%

45%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 18%

$75
Average prescription price

Avg: $70

JOSEPH VANDEN BOSCH MD

Interventional Pain Medicine

1,622

$65.8K

260
159 are 65+

25%
patients receiving schedule two controlled substances

Avg: 48%

42%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 18%

$41
Average prescription price

Avg: $70

RICHARD FERRO DO

Interventional Pain Medicine

1,588

$71.9K

196
96 are 65+

24%
patients receiving schedule two controlled substances

Avg: 48%

55%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 18%

$45
Average prescription price

Avg: $70

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank